Study Name Principal Investigator
(ASPIRE) Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery Nichols, Fenwick
(CONNECT-HF) Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure Dunlap, Stephanie
(GRI RIC) Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study Bruno, Askiel
(Heart-FID) A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency Dunlap, Stephanie
(MASTERS-2) MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study Switzer, Jeffrey
(OPTISON) A Phase 4, Open-Label, Non-randomized, Multicenter Study to Evaluate Safety and Efficacy of Intravenous Administration of OPTISON™ for Contrast-Enhanced Echocardiography in Pediatric Patients Shivaram, Pushpa
(Oxbryta) An Open-label, Expanded Access Protocol for Pediatric Patients with Sickle Cell Disease Who Have No Alternative Treatment Options Mian, Amir
(PERFUSE) AEGIS-II: A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome Arora, Vishal
(SATURN) Statins Use in Intracerebral Hemorrhage Patients Siddu, Mithilesh
(SMART-MSP) Strategic MAnagement to Improve CRT Using Multi-Site Pacing, Post Approval Study Hreibe, Haitham
(TDE-HF-301) A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) in Heart Failure with Preserved Ejection Fraction (HFpEF) McDonough, Clark
(TRANSFORM-HF) Torsemide comparison with furosemide for management of heart failure Dunlap, Stephanie
A Double Blind, Randomized, Sham-procedure controlled, Parallel group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cell (CEP-41750) in Patients with Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction of Either Ischemic or Non-ischemic Etiology Weintraub, Neal
A randomized, multicenter, active-comparator controlled, open-label trial to evaluate efficacy and safety of oral, twice daily LNP023 in adult patients with PNH and residual anemia, despite treatment with an intravenous anti-C5 antibody Kutlar, Abdullah
ABL001E2201 (ASC4MORE): A phase 2, multi-center, open-label, randomized study of oral asciminib added to imatinib versus continued imatinib versus switch to nilotinib in patients with CML-CP who have been previously treated with imatinib and have not achieved deep molecular response Cortes, Jorge
Assessment of Immune Cell function of kidney and kidney pancreas transplant recipients. A marker of strength of immunosuppression resulting from maintenance therapy after transplant: A Single Center Experience MIRZA, AHMAD
C3FIT (Coordinated, Collaborative, Comprehensive, Family-Based, Integrated, and Technology-Enabled Care): A Comparative Effectiveness Randomized Trial to Improve Stroke Care Delivery Switzer, Jeffrey
CLR_15_03: A Two-Part Phase 1/2 Study to Determine Safety, Tolerability, Pharmacokinetics, and Activity of K0706, a Novel Tyrosine Kinase Inhibitor (TKI), in Healthy Subjects and in Subjects with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Cortes, Jorge
Congenital Heart Disease Project to Understand Lifelong Survivor Experience (CHD PULSE) St Louis, James
Connect® MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry Mian, Mohammad
D-Dimer Assay, A Possible Tool in the Evaluation of Atrial Thrombosis Robinson, Vincent
Do Compression Garments Influence the Slow Component of VO2 during a Long Distance Run? Craig-Jones, Andrew
Emperor Reduced: A phase III randomized, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10mg compared to placebo, in patients with chronic Heart Failure and reduced Ejection Fraction (HFrEF) Dunlap, Stephanie
Evaluating Patient-Reported Outcomes Monitoring in Routine Care of Patients with Chronic Myeloid Leukemia for Increasing Adherence and Clinical Response to Therapy: The EMPATHY Pilot Study Kota, Vamsi
Georgia CF Center Longitudinal Phenotyping (CFP30-P) Harris, Ryan
Health benefits of home based whole-body vibration (VIBE-Rx) Harris, Ryan
InformCLL: A Disease Registry for Patients with Chronic Lymphocytic Leukemia Bryan, Locke
Intermittent Fasting in Tactical Athletes Holland, Angelia
JZP025-101: V-FAST: A Phase 1b Master Trial to Investigate CPX-351 Combined with Various Targeted Agents in Subjects with Previously Untreated Acute Myeloid Leukemia Study Cortes, Jorge
Kadmon KD025-013: A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study) Kota, Vamsi
MEI-011: A Two-Stage, Open-Label Followed by Placebo Controlled Phase 2 Study of Pracinostat and Azacitidine in Patients with IPSS-R High and Very High Risk Myelodysplastic Syndromes Previously Untreated with Hypomethylating Agents Pantin, Jeremy
Newborn Biorepository Stansfield, Brian
Ponatinib-3001: A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib versus Imatinib, Administered in Combination with Reduced-intensity Chemotherapy, in Patients with Newly Diagnosed Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) Kota, Vamsi
PrE0404: A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Bryan, Locke
PrE0905: Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML) Kota, Vamsi
Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries Kota, Vamsi
RBC Deformability in Acute Stroke Singh, Dilip
Role of skeletal muscle health on poor lifestyle related type 2 diabetes and cardiovascular disease risk Wang, Xiaoling
Role of Social Determinants of Health and Vascular Aging as Markers of Cardiovascular Disease due to Cancer Therapy Guha, Avirup
Serum measurement of Donor-derived cell-free DNA (dd-cfDNA) for early detection of allograft rejection in Pediatric Kidney Transplants: A Single Center Experience Mirza, Ahmad
SLSG18-301: A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator's Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy Cortes, Jorge
SOFAST: SOFia Aspiration System as first line Technique Rahimi, Scott
The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients with Hematologic Disease Kutlar, Abdullah
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease Annex, Brian
The Roles of HMB and Sodium in Blood Pressure Regulation and Gut Microbiome Chen, Li
Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents (SUMMIT) Bryan, Locke
Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1 (T-St1M) Harris, Ryan
Vascular Risk of Cancer (V-ROC) Harris, Ryan
Xience 90 Study Kapoor, Deepak
RESEARCH. INNOVATION. DISCOVERY.